Research Article
Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome
Table 3
Comparison of the laboratory results between OSAS patients and controls.
| | | OSAS patients (AHI > 5/h)
| Control group (AHI < 5/h)
| |
| | FEV1 (% pred) | 90.18 ± 21.28 | 99.50 ± 23.08 | 0.280 | | FVC (% pred) | 92.83 ± 50.44 | 102.17 ± 19.32 | 0.315 | | FEV1/FVC (%) | 82.39 ± 10.84 | 78.84 ± 9.40 | 0.322 | | pO2 (mmHg) | 76.70 ± 13.24 | 83.87 ± 14.86 | 0.179 | | pCO2 (mmHg) | 40.96 ± 5.44 | 39.41 ± 5.57 | 0.429 | | SBP (mmHg) | 125.70 ± 11.10 | 119.17 ± 12.81 | 0.279 | | DBP (mmHg) | 78.26 ± 7.70 | 75.00 ± 8.36 | 0.401 | Glucose (mg/dL)
(normal range: 70–105) | 112.17 ± 40.72 | 101.50 ± 22.11 | 0.231 | Urea (mg/dL)
(normal range: 17–43) | 36.50 ± 16.16 | 42.20 ± 23.26 | 0.472 | Creatinine (mg/dL)
(normal range: 0.8–1.4) | 0.89 ± 0.15 | 1.00 ± 0.38 | 0.414 | | eGFR (mL/min/1.732) | 93.78 ± 14.85 | 88.78 ± 26.22 | 0.569 | Cholesterol (mg/dL)
(normal values: <200) | 206.34 ± 43.28 | 209.70 ± 45.29 | 0.830 | Triglycerides (mg/dL)
(normal range: 40–160) | 185.47 ± 110.08 | 177.30 ± 119.79 | 0.843 | LDL-C (mg/dL)
(normal values: <140) | 121.24 ± 37.32 | 125.24 ± 40.25 | 0.774 | HDL-C (mg/dL)
(normal values: ≥35) | 46.60 ± 12.81 | 48.80 ± 11.07 | 0.579 | CRP (mg/dL)
(normal values: <0.50) | 0.55 ± 0.57 | 0.32 ± 0.41 | 0.154 | | IL-8 (pg/mL) | 31.79 ± 20.09 | 34.09 ± 14.37 | 0.665 | | Cystatin C (ng/mL) | 1176.13 ± 351.33 | 938.60 ± 245.83 | 0.017 |
|
|
CRP: C-reactive protein, DBP: diastolic blood pressure, eGFR: estimated glomerular filtration rate, FEV1: forced expiratory volume in 1st second, FVC: forced vital capacity, HDL-C: high density lipoprotein cholesterol, IL-8: interleukin 8, LDL-C: low density lipoprotein cholesterol, OSAS: obstructive sleep apnea syndrome, pCO2: partial pressure of CO2, pO2: partial pressure of O2, and SBP: systolic blood pressure.
|
